Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update
16 mars 2023 16h05 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 16, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Laguna Treatment Hospital Warns of Adulterant Xylazine in Illicit Drug Supply
14 mars 2023 16h04 HE
|
Laguna Treatment Hospital
ALISO VIEJO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Laguna Treatment Hospital, a leading provider of substance use and co-occurring mental health treatment, is warning residents about the...
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
08 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
03 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 03, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
02 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Insights on the Nicotine Gum Global Market to 2030 - Featuring Alkalon, Cambrex, Cipla, Enorama Pharma and Fertin Pharma Among Others
01 mars 2023 12h58 HE
|
Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Nicotine Gum Market Research Report by Dosage, Distribution, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation -...
CORRECTION -- Greenhouse Treatment Center Provides Advice for Parents on Counterfeit Pills and Fentanyl Crisis Following Recent Deaths of Local Students
15 févr. 2023 08h03 HE
|
Greenhouse Treatment Center
GRAND PRAIRIE, Texas, Feb. 15, 2023 (GLOBE NEWSWIRE) -- In a release published under the same headline issued February 13th by Greenhouse Treatment Center, please note that in the Teach your kid to...
Greenhouse Treatment Center Provides Advice for Parents on Counterfeit Pills and Fentanyl Crisis Following Recent Deaths of Local Students
13 févr. 2023 15h54 HE
|
Greenhouse Treatment Center
GRAND PRAIRIE, Tx., Feb. 13, 2023 (GLOBE NEWSWIRE) -- With the tragic spate of overdose deaths continuing to occur across the country and among a very young demographic, Greenhouse Treatment Center...
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
07 févr. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
02 févr. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...